HoxB13 mediates AR-V7 activity in prostate cancer

被引：14
|
作者：
Navarro, Hector I. [1 ]
Goldstein, Andrew S. [2 ,3 ,4 ,5 ]
机构：
[1] Univ Calif Los Angeles, Mol Biol Interdept Program, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Broad Stem Cell Res Ctr, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2018年 / 115卷 / 26期
关键词：
ANDROGEN RECEPTOR;
D O I：
10.1073/pnas.1808196115
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：6528 / 6529
页数：2
相关论文
共 50 条
  • [31] HOXB13 Mutation and Prostate Cancer: Studies of Siblings and Aggressive Disease
    Witte, John S.
    Mefford, Joel
    Plummer, Sarah J.
    Liu, Jinghua
    Cheng, Iona
    Klein, Eric A.
    Rybicki, Benjamin A.
    Casey, Graham
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (04) : 675 - 680
  • [32] Selective degradation of AR-V7 to overcome castration resistance of prostate cancer
    Liu, Yuan
    Yu, Cuifu
    Shao, Zhenlong
    Xia, Xiaohong
    Hu, Tumei
    Kong, Weiyao
    He, Xiaoyue
    Sun, Wenshuang
    Deng, Yuanfei
    Liao, Yuning
    Huang, Hongbiao
    CELL DEATH & DISEASE, 2021, 12 (10)
  • [33] Re: Germline Mutations in HOXB13 and Prostate-Cancer Risk
    Bessede, Thomas
    Patard, Jean-Jacques
    EUROPEAN UROLOGY, 2012, 61 (05) : 1062 - 1062
  • [34] Novel HOXB13 variant identified in Galician prostate cancer patients
    Galego Carro, Javier Manuel
    Santamarina, Marta
    Fuentes, Olivia
    Aguado-Barrera, Miguel E.
    Crujeiras, Ana
    Vega, Ana
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 254 - 255
  • [35] A PROSTATE CANCER-ASSOCIATED SNP INCREASES HOXB13 BINDING
    不详
    CANCER DISCOVERY, 2014, 4 (03) : 268 - 268
  • [36] Selective degradation of AR-V7 to overcome castration resistance of prostate cancer
    Yuan Liu
    Cuifu Yu
    Zhenlong Shao
    Xiaohong Xia
    Tumei Hu
    Weiyao Kong
    Xiaoyue He
    Wenshuang Sun
    Yuanfei Deng
    Yuning Liao
    Hongbiao Huang
    Cell Death & Disease, 12
  • [37] Novel selective agents for the degradation of AR/AR-V7 to treat advanced prostate cancer
    Yang, Yifei
    Lv, Guangyao
    Xiu, Ruijuan
    Yang, Huijie
    Wang, Wenyan
    Yu, Pengfei
    Zhang, Jianzhao
    Ye, Liang
    Wang, Hongbo
    Tian, Jingwei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 271
  • [38] Upcycling HOXB13: enhancing prostate cancer detection with a novel antibody
    Augspach, Anke
    Rubin, Mark A.
    JOURNAL OF PATHOLOGY, 2024, 262 (04): : 391 - 394
  • [39] Potential Value of HOXB13 as a Progression Marker for Recurrent Prostate Cancer
    Kang, T.
    Oh, K.
    Nguyen, N.
    Kim, Y.
    Choi, C.
    Kim, M.
    Jung, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S490 - S490
  • [40] Niclosamide in prostate cancer: An inhibitor of AR-V7, a mitochondrial uncoupler, or more?
    Sakellakis, Minas
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 35
12345